This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Biotec Pharmacon Asa. Active years: 2016-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2017
Title: The Innovative Contributions of Ronny Helland
Introduction
Ronny Helland is a notable inventor based in Tromsdalen, Norway. He has made significant contributions to the field of biotechnology, particularly in the development of endonucleases. With a total of 2 patents to his name, Helland's work has implications for various applications in molecular biology.
Latest Patents
Helland's latest patents focus on endonucleases, specifically providing an endonuclease I or enzymatically active fragment thereof. These inventions include sequences that are at least 70% identical to SEQ ID No. 4, with specific modifications to enhance their functionality. The patents also detail methods for removing contaminating polynucleotides from samples using these enzymes, showcasing the practical applications of his research.
Career Highlights
Ronny Helland is associated with Biotec Pharmacon Asa, a company known for its innovative approaches in the pharmaceutical and biotechnology sectors. His work at the company has allowed him to explore and develop groundbreaking technologies that contribute to advancements in the field.
Collaborations
Helland collaborates with talented individuals such as Olav Lanes and Linda Havdalen. These partnerships enhance the research environment and foster innovation within the company.
Conclusion
Ronny Helland's contributions to biotechnology through his patents on endonucleases highlight his role as an influential inventor. His work continues to impact the field, paving the way for future advancements in molecular biology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile